JARID1B downregulation results in the decrease of cell invasion capability. by Yung-Ting Kuo (736349)

Decreasing pixel differences caused by worm movement correspond to decreasing locomotive health. by Areta Jushaj (8525655)

RSV increases apoptosis but decreases ROS production. by Cristina Rojas (667363)

Decreased activity of FASII favors the cold growth of the <i>ΔcshA</i> strain. by Vanessa Khemici (814639)

“…<i>fapR</i> mRNA levels were quantified by RT-qPCR using 16S rRNA as reference gene on total RNAs extracted from <i>wt</i> strain (PR01), <i>ΔcshA</i> strain (PR01-ΔcshA), and suppressor strains <i>ΔcshA/accC</i>^<i>M385V</i> (C51), <i>ΔcshA/accC</i>^<i>T183I</i> (sup30), <i>ΔcshA/accD</i>^<i>F253V</i> (sup17), <i>ΔcshA/accD</i>^<i>A164V</i> (sup16), <i>ΔcshA/birA</i>^{<i>D320F-FsX28</i>} (C58), <i>ΔcshA/birA</i>^{<i>R280stop</i>} (sup1) and <i>ΔcshA/bioY</i>^{<i>P123R-FsX1</i>} (C66), all at exponential growth phase in MH medium at 25°C. n = 5 for <i>ΔcshA</i>, <i>4 for wt</i> and 3 for all others. …”

Step-wise evolution of drug resistance via CNV and LOH. by Pétra Vande Zande (17628246)

<i>Nanos1</i>⁺ cells in the bulb decrease after X-ray irradiation or drug treatments. by Sosuke Fujita (17691623)

Absence of adaptive immunity decreases tumor cell damage in MDR1A deficiency. by Eva Maria Hennenberg (4234018)

TG6-44 treatment leads to a decrease in NP-positive cells and altered expression patterns of NP in A/X31 infected THP-1 cells. by Juan A. De La Cruz (11154187)

TRIM5 restriction of HIV-1 has decreased during evolution leading to humans. by Michael Emerman (12304)

“…<p>The shading of the rectangle represents the degree that TRIM5 will limit infection of HIV-1 (darker color means TRIM5 decreases HIV-1 infection more) and the X-axis indicates time in millions of years from the present. …”

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients by Bai-Wei Gu (740949)

“…Here we describe the production of iPS cells from DC patients with <i>DKC1 </i>mutations <i>Q31E</i>, <i>A353V </i>and <i>ΔL37</i>. …”

K562 cellular proliferation is decreased by RARγ agonist exposure in a time-and concentration-dependent manner. by Melissa D. Kelley (543120)

Different steps of the fabrication process. by Md. Abu Daud (21485629)

Subjects:

ATRA decreases mRNA expression of HO-1, GCLM and x-CT and lowers GSH level in BTZ-treated cells. by A. L. Furfaro (2587792)

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

ATRA decreases the binding of Nrf2 to ARE sequences in the promoter regions of HO-1, GCLM and x-CT in BTZ-treated cells. by A. L. Furfaro (2587792)

Conditional <i>Aff4</i> knockout decreases fat mass in mice. by Yaqian Chen (1711576)

<i>In vivo</i> treatment with 17-AAG decreases <i>L. (V.) braziliensis</i> infection. by Diego M. Santos (111145)

ACE2 overexpression decreases collagen I levels in <i>mdx</i> TA muscle. by Cecilia Riquelme (546116)

<i>Gng5^−/−</i> mutants have decreased cell proliferation and survival. by Anne M. Moon (134982)